Publikationen Abteilung Personalisierte Früherkennung des Prostatakarzinoms
Early detection of prostate cancer?individualized, risk-adapted and successful. [Früherkennung beim Prostatakarzinom ? individualisiert, risikoadaptiert und erfolgreich].
Die Urologie nn, nn (2024) [10.1007/s00120-024-02478-1]
BibTeX |
EndNote:
XML,
Text |
RIS
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial.
Trials 25(1), 754 (2024) [10.1186/s13063-024-08579-8]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate Biopsy: The Transrectal Approach Is Safe.
European urology focus 10(5), 688-690 (2024) [10.1016/j.euf.2024.09.009]
BibTeX |
EndNote:
XML,
Text |
RIS
Screening for Prostate Cancer with Prostate-specific Antigen
European urology open science nn, nn (2024) [10.1016/j.euros.2024.01.010]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate Cancer Screening in Young Men.
Journal of Personalized Medicine 14(8), 818 (2024) [10.3390/jpm14080818]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate cancer screening? Only evidence-based, risk-adjusted, and organized![Prostatakarzinom-Screening? Nur evidenzbasiert, risikoadaptiert und organisiert!]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 67(9), 1047-1053 (2024) [10.1007/s00103-024-03916-3]
BibTeX |
EndNote:
XML,
Text |
RIS
ERSPC trial-prostate-specific antigen (PSA)-based prostate cancer screening in older men.[ERSPC-Studie ? PSA(prostataspezifisches Antigen)-basiertes Prostatakarzinom-Screening bei älteren Patienten].
Die Urologie 63, 1155?1157 (2024) [10.1007/s00120-024-02389-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Treatment of uro-oncology patients: Urology update 2024.[Behandlung uroonkologischer PatientenTreatment of uro-oncology patients].
Die Onkologie 30, 857?862 (2024) [10.1007/s00761-024-01547-6]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
PI-QUAL version 2: the urologist's perspective.
European radiology 34(11), 7063-7064 (2024) [10.1007/s00330-024-10844-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Erratom to: Prostate cancer screening - current overview.[Erratum zu: Das Prostatakarzinom-Screening ? aktueller Überblick].
Die Radiologie 64(7), 545 (2024) [10.1007/s00117-024-01329-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate cancer screening - current overview.[Das Prostatakarzinom-Screening ? aktueller Überblick].
Die Radiologie 64(6), 479?487 (2024) [10.1007/s00117-024-01312-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card.
Healthcare 12(10), 991 (2024) [10.3390/healthcare12100991]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
European urology nn, nn (2024) [10.1016/j.eururo.2024.04.030]
BibTeX |
EndNote:
XML,
Text |
RIS
Corrigendum to 'Lifetime occupational and recreational physical activity and risk of lymphoma subtypes. Results from the European Epilymph case-control study' [Cancer Epidemiol. 87 (2023) 102495].
Cancer epidemiology 89, 102542 (2024) [10.1016/j.canep.2024.102542]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing Program
European urology 85(3), 215-216 (2024) [10.1016/j.eururo.2023.11.026]
BibTeX |
EndNote:
XML,
Text |
RIS
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study
European urology open science 59, 30 - 38 (2024) [10.1016/j.euros.2023.10.005]
BibTeX |
EndNote:
XML,
Text |
RIS
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
European urology 85(2), 105-111 (2024) [10.1016/j.eururo.2023.09.027]
BibTeX |
EndNote:
XML,
Text |
RIS
Re: Association of Prostate-specific Antigen Screening Rates with Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities: Prostate cancer screening needs not only to be well meant but also well done.
European urology 83(4), 369-370 (2023) [10.1016/j.eururo.2022.12.003]
BibTeX |
EndNote:
XML,
Text |
RIS
Adherence to a risk-adapted screening strategy for prostate cancer - first results of the PROBASE trial
International journal of cancer 152(5), 854-864 (2023) [10.1002/ijc.34295]
BibTeX |
EndNote:
XML,
Text |
RIS
Lifetime occupational and recreational physical activity and risk of lymphoma subtypes. Results from the European Epilymph case-control study.
Cancer epidemiology 87, 102495 (2023) [10.1016/j.canep.2023.102495]
BibTeX |
EndNote:
XML,
Text |
RIS
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
European urology oncology 6(6), 566-573 (2023) [10.1016/j.euo.2023.09.008]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate cancer-multiparametric MRI and alternative approaches in intervention and therapy planning.[Multiparametrische MRT und alternative Methoden in der Interventions- und Behandlungsplanung beim Prostatakarzinom].
Die Urologie 62(11), 1160-1168 (2023) [10.1007/s00120-023-02190-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Göteborg 2 study-early PSA-based prostate cancer screening prior to the age of 55 years.[Göteborg-2-Studie ? PSA(prostataspezifisches Antigen)-basiertes Prostatakarzinomscreening mit frühzeitigem Start vor dem 55. Lebensjahr].
Die Urologie 62(7), 727-729 (2023) [10.1007/s00120-023-02112-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit.
The BMJ 381, e071082 (2023) [10.1136/bmj-2022-071082]
BibTeX |
EndNote:
XML,
Text |
RIS
Systematic or targeted fusion-guided biopsy.[Systematische oder gezielte Fusionsbiopsie der Prostata.]
Die Urologie 62(5), 464-472 (2023) [10.1007/s00120-023-02062-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011
European urology focus 8(3), 646-647 (2022) [10.1016/j.euf.2022.04.001]
BibTeX |
EndNote:
XML,
Text |
RIS
Cognitive function in patients undergoing cystectomy for bladder cancer ? results from a prospective observational study
Therapeutic advances in urology 14, 175628722210876 - (2022) [10.1177/17562872221087660]
BibTeX |
EndNote:
XML,
Text |
RIS
A Randomized Trial of Risk-Adapted Screening for Prostate Cancer in Young Men - Results of the First Screening Round of the PROBASE Trial.
International journal of cancer 150(11), 1861-1869 (2022) [10.1002/ijc.33940]
BibTeX |
EndNote:
XML,
Text |
RIS
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer.
European urology oncology 4(5), 731-739 (2021) [10.1016/j.euo.2021.06.006]
BibTeX |
EndNote:
XML,
Text |
RIS
Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy.
European urology 80(1), e28-e29 (2021) [10.1016/j.eururo.2021.04.027]
BibTeX |
EndNote:
XML,
Text |
RIS
Solving problems is smart, preventing them is wise: lessons learned from the 2nd International DKFZ Conference on Cancer Prevention.
International journal of cancer 148(12), 3086-3096 (2021) [10.1002/ijc.33502]
BibTeX |
EndNote:
XML,
Text |
RIS
PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector.[PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen: Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krankenhaussektor].
Nuklearmedizin 60(3), 216-223 (2021) [10.1055/a-1351-0030]
BibTeX |
EndNote:
XML,
Text |
RIS
Occupational exposure to organic dust and risk of lymphoma subtypes in the EPILYMPH case-control study.
Scandinavian journal of work, environment & health 47(1), 42 - 51 (2021) [10.5271/sjweh.3925]
BibTeX |
EndNote:
XML,
Text |
RIS
Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.
European urology 79(3), 327-329 (2021) [10.1016/j.eururo.2020.12.010]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania.
Journal of Clinical Medicine 9(12), 3826 (2020) [10.3390/jcm9123826]
BibTeX |
EndNote:
XML,
Text |
RIS
Occupational exposure to ionizing radiation and risk of lymphoma subtypes: results of the Epilymph European case-control study.
Environmental health 19(1), 43 (2020) [10.1186/s12940-020-00596-9]
BibTeX |
EndNote:
XML,
Text |
RIS